Come up with a name for your new list and we'll add to it:
M.I.N.D. Pharmaceuticals raised a round of funding on June 13, 2017. Investors include
i.Lab at UVA.
M.I.N.D. Pharmaceuticals is developing medicine based on natural biological nanoparticles for disease treatment and non-invasive diagnostics for early detection, as well as skincare/beauty products.…